Lamotrigine

Lamotrigine

Nazwa produktu Lamotrigine
Numer CAS 84057-84-1
Wzór cząsteczkowy C9H7Cl2N5
Masa cząsteczkowa 256.09
Wygląd Biały lub prawie biały krystaliczny proszek
Oznaczenie (HPLC) 98.0% - 101.0%
Strata przy suszeniu ≤ 0,5%
Popiół po spaleniu ≤ 0,11 TP3T
Metale ciężkie ≤ 10 ppm
Temperatura topnienia 216°C - 220°C
Współczynnik obrotowy Not applicable (achiral)

Potrzebujesz pomocy? Skontaktuj się z naszym zespołem

Synonyms :Lamictal, BW-430C, 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine, 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine, Lamotrigine base, Lamotrigine USP

Lamotrigine is a phenyltriazine derivative that functions as an anticonvulsant and mood-stabilizing agent. It is primarily used in the management of epilepsy and bipolar disorder, where it helps to stabilize neuronal membranes by blocking voltage-sensitive sodium channels and inhibiting the release of excitatory neurotransmitters, particularly glutamate. This mechanism of action contributes to its efficacy in reducing seizure frequency and preventing mood episodes.

As a pharmaceutical intermediate, lamotrigine is a key active pharmaceutical ingredient (API) in the production of antiepileptic and psychiatric medications. Its well-characterized profile and established therapeutic benefits make it a valuable compound for both research and commercial applications.

Funkcja

  • Anticonvulsant Activity: Inhibits voltage-gated sodium channels, stabilizing presynaptic neuronal membranes and reducing abnormal electrical discharges in the brain.
  • Glutamate Release Inhibition: Modulates the release of excitatory amino acids, particularly glutamate, thereby dampening excitatory neurotransmission and preventing seizure propagation.
  • Mood Stabilization: Exhibits efficacy in bipolar disorder by prolonging the time to depressive and manic episodes, likely through similar ion channel modulation and neurotransmitter regulation.
  • Neuroprotective Effects: Demonstrates potential neuroprotective properties in models of ischemia and excitotoxicity, supporting its use in neurological conditions.

Źródło i czystość

  • Źródło: Synthetic compound produced via chemical synthesis, with high purity suitable for pharmaceutical use.
  • Normalizacja: Conforms to USP/EP specifications; assay (HPLC) 98.0% – 101.0% on dried basis.
  • Formularze: Available as a crystalline powder, typically in bulk quantities for formulation or further processing.
  • Zastosowania: Used as an API in tablets, oral suspensions, and other dosage forms for epilepsy and bipolar disorder; also employed in research and development.

Dokumentacja i zaopatrzenie

  • Dokumentacja: certyfikat pochodzenia (COA), karta charakterystyki substancji niebezpiecznej (MSDS), karta techniczna produktu (TDS)
  • Czas realizacji: 7-15 days after order confirmation, depending on quantity and destination.
  • Opakowanie: Supplied in double polyethylene bags inside fiber drums or as per customer request; net weight 25 kg per drum.

Zapytanie ofertowe

  • Nasz adres: 280 Main Street, Xi’an, Shaanxi, Chiny
  • LyvBio Sp. z o.o. — E-mail: info@lyvbio.com

How to Order Lamotrigine  from LyvBio? It’s simple!

Just drop us an email at info@lyvbio.com and let us know:

How many you need?

Your shipping address?

We’ll get back to you within 24 hours with pricing, COA, and shipping details. We support sample orders and bulk shipments, with DDP available for Europe.

BĄDŹ W KONTAKCIE

Zapytanie ofertowe

Nasz adres

ul. Główna 280, Xi’an, Shaanxi, Chiny

×